Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cressey

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|October 3, 2018
Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B VirusTim R Cressey, Linda Harrison, Jullapong Achalapong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2015
New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in ThailandPrakit Riyaten, Nicolas Salvadori, Patrinee Traisathit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B VirusNicolas Salvadori, Bo Fan, Waralee Teeyasoontranon, et al.
The Lancet. HIV|October 11, 2025
Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trialAdrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
BMJ Open|October 6, 2021
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomesAshley R Bardon, Jienchi Dorward, Yukteshwar Sookrajh, et al.
BMC Medical Research Methodology|February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
BMC Infectious Diseases|August 11, 2016
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigenGonzague Jourdain, Nicole Ngo-Giang-Huong, Tim R Cressey, et al.
Bulletin of the World Health Organization|December 2, 2025
Target product profiles for paediatric formulations of azithromycin and nitrofurantoinYasir Bin Nisar, Giulia Brigadoi, Shabina Ariff, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|October 3, 2018
Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B VirusTim R Cressey, Linda Harrison, Jullapong Achalapong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2015
New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in ThailandPrakit Riyaten, Nicolas Salvadori, Patrinee Traisathit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B VirusNicolas Salvadori, Bo Fan, Waralee Teeyasoontranon, et al.
The Lancet. HIV|October 11, 2025
Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trialAdrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2023
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026sMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
BMJ Open|October 6, 2021
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomesAshley R Bardon, Jienchi Dorward, Yukteshwar Sookrajh, et al.
BMC Medical Research Methodology|February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
BMC Infectious Diseases|August 11, 2016
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigenGonzague Jourdain, Nicole Ngo-Giang-Huong, Tim R Cressey, et al.
Bulletin of the World Health Organization|December 2, 2025
Target product profiles for paediatric formulations of azithromycin and nitrofurantoinYasir Bin Nisar, Giulia Brigadoi, Shabina Ariff, et al.
Pageof 16